Slashdot lists the best HOMER Energy alternatives on the market that offer competing products that are similar to HOMER Energy.University of the East, Ramon Magsaysay Memorial Medical Center, Quezon City, PHL, MD, Doctor of MedicineStrong Virial / Potential Energy Correlations, and the Many Consequences for Viscous Liquids Thomas B. Compare ratings, reviews, pricing, and features of HOMER Energy alternatives in 2021. Find the top alternatives to HOMER Energy currently available. Best HOMER Energy Alternatives in 2021.
Compare features, ratings, user reviews, pricing, and more from HOMER Energy competitors and alternatives in order to make an informed decision for your business. SourceForge ranks the best alternatives to HOMER Energy in 2021. Dyre KITP, 2010Compare HOMER Energy alternatives for your business or organization using the curated list below. Pedersen, Nicholas Bailey, Jeppe C.
Homer Energy Correlation Free Survival Following
Teyateeti A, Teyateeti A, Ravizzini GC, Xu G, Tang C, Tu SM, Macapinlac, H, Lu Y. Nucl Med Commun 42(7):755-762, 2021. Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer. Baiomy A, Schellingerhout D, Chapin BF, Weinberg JS, Raza SM, Macapinlac, HA, Ravizzini G. Eur J Nucl Med Mol Imaging 48(9):2883-2893, 2021. 18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study.
Subbiah V, Erwin W, Mawlawi O, McCoy A, Wages D, Wheeler C, Gonzalez-Lepera C, Liu H, Macapinlac HA, Meric-Bernstam F, Hong DS, Pant S, Le D, Santos E, Gonzalez J, Roszik J, Suzuki T, Subach RA, Madden T, Johansen M, Nomura F, Satoh H, Matsuura T, Kajita M, Nakamura E, Funase Y, Matsushima S, Ravizzini G. Diagnostics (Basel) 11(1), 2020. A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis. Kairemo K, Kappadath SC, Joensuu T, Macapinlac HA. Am J Nucl Med Mol Imaging 11(2):87-98, 2021.
Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?. Teyateeti A, Macapinlac, HA, Lu Y. Clin Cancer Res 26(22):5830-5842, 2020.
Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan M, Nandivada V, Kaur I, Nunez Cortes A, Cao K, Daher M, Hosing C, Cohen EN, Kebriaei P, Mehta R, Neelapu S, Nieto Y, Wang M, Wierda W, Keating M, Champlin R, Shpall EJ, Rezvani K. Eur J Nucl Med Mol Imaging 47(7):1620-1622, 2020. Nuclear medicine in responding to global pandemic COVID-19-American College of Nuclear Medicine member experience. Lu Y, Yan SX, Lan X, Zhu X, Macapinlac, HA.
Alpha particle Radium 223 dichloride in high-risk osteosarcoma: a phase I dose escalation trial. Subbiah V, Anderson PM, Kairemo K, Hess K, Huh WW, Ravi V, Daw NC, Somaiah N, Ludwig JA, Benjamin RS, Chawla S, Hong DS, Meric-Bernstam F, Ravizzini G, Kleinerman E, Macapinlac, HA, Rohren E. Nucl Med Commun 40(9):940-946, 2019. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer. Chen B, Wei P, Macapinlac, HA, Lu Y. N Engl J Med 382(6):545-553, 2020.
J Nucl Med 56(10):1507-12, 2015. DETERMINATION OF SKELETAL TUMOR BURDEN ON 18F-FLUORIDE PET/CT. Rohren EM, Etchebehere EC, Araujo JC, Hobbs BP, Swanston NM, Everding M, Moody T, Macapinlac HA. ESMO Open 4(1):e000439, 2019. Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST. Kairemo K, Rohren EM, Anderson PM, Ravizzini G, Rao A, Macapinlac HA, Subbiah V.
Erasmus JJ, Macapinlac HA. Cancer Sci 103(9):Septembercover, 2012. (18) F-FDG PET/CT images reveal a focal hypermetabolic focus of the primary tumor (upper panel), whereas (11) C-choline PET/CT images reveal only a focal hypermetabolic focus in the primary tumor (lower panel).
Homer Energy Correlation Plus ABVD In
Phase II study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. Younes A, Oki Y, McLaughlin P, Copeland AR, Goy A, Pro B, Feng L, Yuan Y, Chuang HH, Macapinlac HA, Hagemeister F, Romaguera J, Samaniego F, Fanale MA, Dabaja BS, Rodriguez MA, Dang N, Kwak LW, Neelapu SS, Fayad LE. Semin Nucl Med 42(4):255-60, 2012.
Radiology 263(1):53-63, 2012. Neoadjuvant Chemotherapy in Breast Cancer: Prediction of Pathologic Response with PET/CT and Dynamic Contrast-enhanced MR Imaging-Prospective Assessment. Tateishi U, Miyake M, Nagaoka T, Terauchi T, Kubota K, Kinoshita T, Daisaki H, Macapinlac HA.
0 kommentar(er)
